Welcome to our dedicated page for Vita Coco Company SEC filings (Ticker: COCO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Vita Coco Company, Inc. (NASDAQ: COCO) files reports and disclosures with the U.S. Securities and Exchange Commission as part of its obligations as a public company. This page compiles those SEC filings and pairs them with AI-powered tools that help explain the information contained in key documents.
Through its filings, the company reports on topics such as quarterly and annual financial performance, business developments, and regulatory matters. Recent Form 8-K filings, for example, reference press releases announcing financial results for quarters ended June 30 and September 30, 2025, as well as a company statement regarding tariff relief affecting coconut water products. These filings provide detail on net sales, gross profit, net income, and non-GAAP measures like Adjusted EBITDA, along with management’s commentary on factors such as tariffs, costs, and demand for Vita Coco Coconut Water and related products.
On this page, users can access core documents such as annual reports on Form 10-K, quarterly reports on Form 10-Q, and current reports on Form 8-K as they become available through EDGAR. AI-generated summaries are designed to highlight major themes, clarify technical language, and surface items that may matter to shareholders, such as segment performance, tariff discussions, or capital allocation programs mentioned in earnings releases.
In addition, this page provides convenient access to insider transaction reports on Form 4 and other ownership-related filings when they are filed. Together, these resources allow investors, analysts, and interested readers to review The Vita Coco Company’s regulatory disclosures in one place, with AI assistance to make complex filings easier to understand.
COCO submitted a Form 144 notice reporting sales of Common Stock by Charles Van Es. The excerpt lists three dispositions: 2,000 shares on 03/16/2026 for $115,960, 2,000 shares on 04/01/2026 for $97,340, and 2,000 shares on 05/01/2026 for $133,740. The filing also lists several restricted stock vesting events issued as compensation on various dates, with unit counts shown.
Filer submitted a Form 144 reporting a proposed sale of 20,000 shares of Common Stock. The entry lists 20,000 shares with an aggregate amount of $1,400,000.00 and an "as of" date of 05/08/2026. The record also shows prior sales by Jonathan Burth of 60,000, 40,000, and 20,000 shares on 03/16/2026, 04/29/2026, and 04/30/2026 respectively with listed proceeds.
Vita Coco Company, Inc. Chief Commercial Officer Charles van Es reported an open-market sale of 2,000 shares of Common Stock at $66.87 per share. Following this sale, he directly holds 75,691 Common Stock shares. The filing also lists multiple outstanding non-qualified stock options that are vested or scheduled to vest over time, with exercise prices ranging from $10.178 to $33.36 per share and expiration dates extending through 2035. A footnote states the sale was executed under a pre-arranged Rule 10b5-1 trading plan.
Vita Coco Company, Inc. director and Executive Chairman Michael Kirban reported an insider transaction involving a trust he is associated with. On the reported date, the Michael Kirban Revocable Trust sold 50,000 shares of common stock at $68.00 per share in an open‑market transaction carried out under a Rule 10b5‑1 trading plan. Following this sale, that revocable trust held 515,681 shares of Vita Coco common stock. Separately, the filing shows 1,479,049 shares of common stock held indirectly by the Michael Kirban 2010 Trust and 143,799 shares held directly, along with several blocks of non‑qualified stock options with exercise prices ranging from $10.178 to $32.78 per share and expirations between 2029 and 2035.
Vita Coco Company, Inc. Chief Operating Officer Jonathan Burth executed an exercise-and-sell trading pattern under a Rule 10b5-1 trading plan. On April 29–30, 2026, he exercised options to acquire 60,000 shares of common stock at an exercise price of about $10.178 per share and sold 60,000 shares in open-market transactions at prices ranging from $62.50 to $67.50 per share. Following these transactions, he directly owns 57,910 shares of common stock and retains several non-qualified stock option awards with exercise prices between $10.178 and $33.36 per share expiring between 2030 and 2035.
COCO filing discloses resale activity and a restricted stock vesting. The record shows a restricted stock vesting of 2,000 shares on 11/27/2024 issued as compensation. It also lists two resale transactions by Charles Van Es: 2,000 shares sold for $115,960 on 03/16/2026 and 2,000 shares sold for $97,340 on 04/01/2026.
Vita Coco Company, Inc. director and Chief Executive Officer Martin Roper reported an exercise-and-sell transaction in company stock. He exercised stock options to acquire a total of 45,544 shares of common stock at an exercise price of $10.178 per share, then sold the same 45,544 shares in open-market transactions on two days at weighted average prices of $51.13 and $59.348 per share.
The filing states that these sales were effected under a Rule 10b5-1 trading plan. Following the transactions, Roper directly holds 298,484 shares of common stock. The filing also lists indirect holdings in shares held by his spouse and several Exempt Family Trusts, as well as multiple remaining non-qualified stock option awards with exercise prices ranging from $10.178 to $32.78 and expirations extending to 2035.
COCO affiliate filed a Form 144 proposing sale of 20,000 shares of Common Stock. The filing lists a 20,000-share sale dated 04/30/2026 tied to an option granted 02/10/2020. The record also shows insider sales by Jonathan Burth of 60,000 and 40,000 shares on 03/16/2026 and 04/29/2026, respectively.
The issuer COCO filed a Form 144 notice reporting proposed and recent sales of Common Stock by affiliated holders and a trust. The filing lists a 50,000-share block associated with Fidelity Brokerage Services and two reported sales by the Michael Kirban Revocable Trust of 9,796 shares on 03/11/2026 and 40,204 shares on 03/12/2026.
COCO reported a Rule 144 notice showing 40,000 shares of Common Stock to be sold by Fidelity Brokerage Services LLC on 04/29/2026 for $2,550,000. The filing also records that Jonathan Burth sold 60,000 shares on 03/16/2026 for $3,519,200. The sale is linked to an option granted on 02/10/2020 and the planned sale method is cash.